ID: ALA5206893

Max Phase: Preclinical

Molecular Formula: C13H10ClN3O

Molecular Weight: 259.70

Associated Items:

Representations

Canonical SMILES:  COc1cc2c(-n3ccnc3)ccnc2cc1Cl

Standard InChI:  InChI=1S/C13H10ClN3O/c1-18-13-6-9-11(7-10(13)14)16-3-2-12(9)17-5-4-15-8-17/h2-8H,1H3

Standard InChI Key:  RGOXVKQTERWXMC-UHFFFAOYSA-N

Associated Targets(Human)

Cyclic GMP-AMP synthase 693 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 259.70Molecular Weight (Monoisotopic): 259.0512AlogP: 3.08#Rotatable Bonds: 2
Polar Surface Area: 39.94Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 6.44CX LogP: 2.34CX LogD: 2.30
Aromatic Rings: 3Heavy Atoms: 18QED Weighted: 0.71Np Likeness Score: -1.56

References

1. Wang X, Liu Y, Han X, Zou G, Zhu W, Shen H, Liu H..  (2021)  Small molecule approaches to treat autoimmune and inflammatory diseases (Part II): Nucleic acid sensing antagonists and inhibitors.,  44  [PMID:33984476] [10.1016/j.bmcl.2021.128101]

Source